(Benzothiazol-2-yl)-(Z)-2-trityloxyimino-2-(2-aminothiazole-4-yl)-thioacetate

We are (Benzothiazol-2-yl)-(Z)-2-trityloxyimino-2-(2-aminothiazole-4-yl)-thioacetate CAS:143183-03-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:
(Benzothiazol-2-yl)-(Z)-2-trityloxyimino-2-(2-aminothiazole-4-yl)-thioacetate
CAS.NO:143183-03-3
Synonyms:(Z)-2-(2-Aminothiazol-4-yl)-2-trityloxyiminothioacetic acid benzothiazole ester
2-mercaptobenzothiazolyl (z)-2-(2-aminothiazol-4-yl)-2-trityloxyiminoacetate
BTATA
BEAM
Molecular Formula:C31H22N4O2S3
Molecular Weight:578.72700
 
Physical and Chemical Properties:
Density:1.557
Boiling point:520ºC
Flash point:268.3ºC
Index of Refraction:1.721
 
Specification:
Appearance:Off-white to light yellow crystalline powder
Purity:≥98.0%
Loss on drying:≤0.5%
Total impurities:≤2.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:For the synthesis of cefdinir

(Benzothiazol-2-yl)-(Z)-2-trityloxyimino-2-(2-aminothiazole-4-yl)-thioacetate


Related News: In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.4-Chlorobutyl Acetate In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.Linolenato de metilo CAS:301-00-8 In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.2-Fluoropyridine-6-carboxylic acid “With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”“With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”

Related Products
Product Name
Cyclopropylboronic acid View Details
N-ETHYLFORMAMIDE View Details
2-((1-Benzylpiperidin-4-yl)methylene)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one View Details
3-bromo-5-methylpyridine manufacturer 9-(4-Bromophenyl)-10-phenylanthracene manufacturer 4-Aminopiperidine manufacturer Methyl 6-Bromohexanoate manufacturer 2,6-Dimethylpyrazine manufacturer